Cite
HARVARD Citation
van Nimwegen, J. et al. (2020). Abatacept treatment for patients with early active primary Sjögren's syndrome: a single-centre, randomised, double-blind, placebo-controlled, phase 3 trial (ASAP-III study). Lancet. pp. e153-e163. [Online].